Oxoboranes have been synthetic targets for more than 60 years and were thought to be too unstable to be isolated. In a new publication, Würzburg chemists have now shattered this paradigm.

Multifunctional Nanodiamond Conjugate With a Tumor-Specific EGFR-Targeting Peptide and Photoactivated CO Release for Improved Therapeutic Efficacy in Head and Neck Cancers

Uncaging Iridium(III) Complexes for Combined Photodynamic and Photoactivated Chemotherapy